Online citations, reference lists, and bibliographies.
← Back to Search

Heterogeneity In Chronic Fatigue Syndrome: Evidence From Magnetic Resonance Spectroscopy Of Muscle

R. Lane, M. C. Barrett, Doris J. Taylor, G. Kemp, R. Lodi
Published 1998 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
It has been shown previously that some patients with chronic fatigue syndrome show an abnormal increase in plasma lactate following a short period of moderate exercise, in the sub-anaerobic threshold exercise test (SATET). This cannot be explained satisfactorily by the effects of 'inactivity' or 'deconditioning', and patients with abnormal lactate responses to exercise (SATET +ve) have been found to have significantly fewer Type 1 muscle fibres in quadriceps biopsies than SATET -ve patients. We performed phosphorus magnetic resonance spectroscopy on forearm muscles of 10 SATET +ve patients, 9 SATET -ve patients and 13 sedentary volunteers. There were no differences in resting spectra between these groups but at the end of exercise, intracellular pH in the SATET +ve patients was significantly lower than in both the SATET -ve cases and controls (P < 0.03), and the SATET +ve patients also showed a significantly lower ATP synthesis rate during recovery (P < 0.01), indicating impaired mitochondrial oxidative phosphorylation. These observations support other evidence which indicates that chronic fatigue syndrome is a heterogeneous disorder, and confirms the view that some chronic fatigue syndrome patients have a peripheral component to their fatigue.
This paper references
10.1016/s0021-9258(18)50401-4
Cytosolic phosphorylation potential.
R. Veech (1979)
10.1016/S0140-6736(84)91871-3
EXCESSIVE INTRACELLULAR ACIDOSIS OF SKELETAL MUSCLE ON EXERCISE IN A PATIENT WITH A POST-VIRAL EXHAUSTION/FATIGUE SYNDROME A 31P Nuclear Magnetic Resonance Study
D. Arnold (1984)
10.1002/ANA.410180205
Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
D. Arnold (1985)
10.1016/S0163-4453(85)92488-0
The postviral fatigue syndrome--an analysis of the findings in 50 cases.
P. O. Behan (1985)
10.1136/jnnp.48.7.691
Electrophysiological studies in the post-viral fatigue syndrome.
G. Jamal (1985)
10.1111/J.1445-5994.1985.TB04042.X
Chronic relapsing myalgia (? Post viral): clinical, histological, and biochemical studies.
E. Byrne (1985)
10.1002/MUS.880090710
A double‐blind, placebo‐controlled, crossover study of verapamil in exertional muscle pain
R. Lane (1986)
10.1002/MUS.880100213
Remarkable resistance of the nerve to ischemia: a reply.
Parry Gj (1987)
10.1136/jnnp.50.6.743
Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle.
E. Byrne (1987)
10.1136/bmj.297.6655.1014
Normal muscle strength and fatigability in patients with effort syndromes.
M. Stokes (1988)
10.1177/014107688808100608
Postviral Fatigue Syndrome: Persistence of Enterovirus RNA in Muscle and Elevated Creatine Kinase
L. Archard (1988)
10.1007/978-3-642-74539-3
Anion Carriers of Mitochondrial Membranes
A. Azzi (1989)
10.1007/978-3-642-74539-3_31
Control of Mitochondrial Energy Production in Vivo
D. Taylor (1989)
10.1136/jnnp.52.9.1090
Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET).
L. Nashef (1989)
10.1177/014107689108400123
Mania and Recovery from Chronic Fatigue Syndrome
M. Sharpe (1991)
10.1212/WNL.41.1.114
In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondria1 disease
P. Matthews (1991)
10.1177/014107689108400224
A Report–Chronic Fatigue Syndrome: Guidelines for Research
M. Sharpe (1991)
10.1093/OXFORDJOURNALS.BRAIN.A101869
Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome.
A. Lloyd (1991)
Chronic fatigue syndrome: studies on skeletal muscle.
J. Grau (1992)
10.1378/CHEST.102.6.1716
Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy.
R. Wong (1992)
10.1212/WNL.43.1_Part_1.125
Central basis of muscle fatigue in chronic fatigue syndrome
J. Kent-braun (1993)
10.1136/jcp.46.8.722
Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome.
V. Preedy (1993)
10.1002/NBM.1940060504
Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise
G. Kemp (1993)
10.1002/9780470514382.CH7
Muscle histopathology and physiology in chronic fatigue syndrome.
R. Edwards (1993)
10.1136/jnnp.56.6.679
Skeletal muscle bioenergetics in the chronic fatigue syndrome.
P. R. Barnes (1993)
10.1002/NBM.1940060111
Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle
G. Kemp (1993)
10.1136/jnnp.57.3.375
Single fibre EMG studies in chronic fatigue syndrome: a reappraisal.
L. Roberts (1994)
10.1016/0022-510X(94)90073-6
Bioenergetics of skeletal muscle in mitochondrial myopathy
D. Taylor (1994)
10.1136/jnnp.57.5.662-a
Lactate responses to exercise in chronic fatigue syndrome.
R. Lane (1994)
10.1136/bmj.311.7004.544
Exercise responses and psychiatric disorder in chronic fatigue syndrome
R. Lane (1995)
10.1017/S0033291700037417
Can the chronic fatigue syndrome be defined by distinct clinical features?
I. Hickie (1995)
10.1002/(SICI)1097-4598(199605)19:5<621::AID-MUS10>3.0.CO;2-Q
Reduced oxidative muscle metabolism in chronic fatigue syndrome
K. McCully (1996)
Chronic fatigue syndrome and skeletal muscle mitochondrial function.
R. Lodi (1997)
10.1097/00005072-199704000-00014
Handbook of Muscle Disease
R. Lane (1997)
10.1016/S0960-8966(97)00426-4
Abnormal oxidative metabolism in exercise in exercise intolerance of undetermined origin
Z. Argov (1997)
10.1136/jnnp.64.3.362
Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome
R. Lane (1998)



This paper is referenced by
10.14198/jhse.2021.163.01
Effect of exercise on cancer-related fatigue: A systematic review
S. Cataldi (2020)
10.1186/s12967-019-1836-0
Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
M. J. Nelson (2019)
10.3390/diagnostics9030080
Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Daniel Missailidis (2019)
10.1080/21641846.2019.1580855
The role of mitochondria in ME/CFS: a perspective
Cara Tomas (2019)
10.1016/j.phrs.2019.104450
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: From Pathophysiological Insights to Novel Therapeutic Opportunities.
G. Morris (2019)
10.1038/s41598-019-55473-4
Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome
A. Ghali (2019)
10.1080/09553002.2018.1422871
Chronic fatigue and immune deficiency syndrome (CFIDS), cellular metabolism, and ionizing radiation: a review of contemporary scientific literature and suggested directions for future research
A. Rusin (2018)
10.1042/BST20170503
Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review.
Cara Tomas (2018)
10.1007/s11926-017-0628-x
Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings
M. Gerwyn (2017)
Investigating the biochemical basis of muscle cell dysfunction in chronic fatigue syndrome
G. Rutherford (2016)
10.1093/bmb/ldv057
The aetiopathogenesis of fatigue: unpredictable, complex and persistent
J. Clark (2016)
10.1186/s12967-016-0771-6
Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome
Paul Billing-Ross (2016)
10.1155/2016/2497348
Understanding Muscle Dysfunction in Chronic Fatigue Syndrome
G. Rutherford (2016)
Effects of Exercise Training on Physiological and Psychological Measurements of Cancer-Related Fatigue
T. Manikowske (2016)
10.1016/j.bpc.2015.03.009
In silico analysis of exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.
N. Lengert (2015)
Prolonged Abnormal Effects of Exercise in Myalgic Encephalomyelitis and Chronic Fatigue Syndrome
Frank N M Twisk (2015)
10.1016/j.jpsychores.2015.10.005
Increased risk of chronic fatigue syndrome in patients with migraine: A retrospective cohort study.
C. Lau (2015)
10.1097/j.pain.0000000000000110
Evidence for sensitized fatigue pathways in patients with chronic fatigue syndrome
R. Staud (2015)
10.1186/s12916-015-0310-y
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
G. Morris (2015)
10.3390/biology3030606
Discerning Primary and Secondary Factors Responsible for Clinical Fatigue in Multisystem Diseases
D. Maughan (2014)
10.1111/eci.12201
Recovery of upper limb muscle function in chronic fatigue syndrome with and without fibromyalgia
K. Ickmans (2014)
10.2174/1570159X11666131120224653
Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
G. Morris (2014)
10.3390/toxins5040605
Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome
J. Brewer (2013)
10.1186/1741-7015-11-64
A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior
G. Morris (2013)
10.1007/s12035-013-8477-8
Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications
G. Morris (2013)
10.1186/1741-7015-11-205
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
G. Morris (2013)
10.1007/174_2013_847
MR Spectroscopy and Spectroscopic Imaging for Evaluation of Skeletal Muscle Metabolism: Basics and Applications in Metabolic Diseases
C. Boesch (2013)
10.1517/14728222.2013.818657
The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?
M. Meeus (2013)
10.1007/s11011-013-9435-x
Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways
G. Morris (2013)
10.1016/j.psychres.2012.03.031
Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: Results of supervised learning techniques applied on clinical and inflammatory data
M. Maes (2012)
O P I N I O N Open Access
M. Blinov (2012)
10.1016/S1734-1140(12)70930-1
Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice.
A. Kumar (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar